Opus Genetics Inc [NASDAQ: IRD] jumped around 882869.03 points on Thursday, while shares priced at $882870.0 at the close of the session, up 5.13%.
Compared to the average trading volume of 882.87K shares, IRD reached a trading volume of 9481354 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Opus Genetics Inc [IRD]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for IRD shares is $6.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on IRD stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Craig Hallum have made an estimate for Opus Genetics Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on April 11, 2025. While these analysts kept the previous recommendation, H.C. Wainwright raised their target price to Buy. The new note on the price target was released on November 13, 2024, representing the official price target for Opus Genetics Inc stock.
The Price to Book ratio for the last quarter was 9.15, with the Price to Cash per share for the same quarter was set at 0.70.
How has IRD stock performed recently?
Opus Genetics Inc [IRD] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 9.52. With this latest performance, IRD shares dropped by 0.00% in over the last four-week period, additionally plugging by 4.24% over the last 6 months – not to mention a drop of -14.29% in the past year of trading.
Opus Genetics Inc [IRD]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Opus Genetics Inc [IRD] shares currently have an operating margin of -265.88%. Opus Genetics Inc’s Net Margin is presently recorded at -429.42%.
Return on Equity for this stock declined to -117.23%, with Return on Assets sitting at -117.23%.
Earnings analysis for Opus Genetics Inc [IRD]
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for IRD. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Opus Genetics Inc go to 32.46%.
